Cargando…
A new diagnostic indication device of a biomarker growth differentiation factor 15 for mitochondrial diseases: From laboratory to automated inspection
Mitochondrial diseases (MDs) are occasionally difficult to diagnose. Growth differentiation factor 15 (GDF15) has been reported as a biomarker useful for not only diagnosing MDs, but also evaluating disease severity and therapeutic efficacy. To enable the measurement of serum GDF15 concentrations at...
Autores principales: | Koga, Yasutoshi, Povalko, Nataliya, Inoue, Eisuke, Ishii, Akiko, Fujii, Katsunori, Fujii, Tatsuya, Murayama, Kei, Mogami, Yukiko, Hata, Ikue, Ikawa, Masamichi, Fukami, Kei, Fukumoto, Yoshihiro, Nomura, Masatoshi, Ichikawa, Kazuki, Yoshida, Kaori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048444/ https://www.ncbi.nlm.nih.gov/pubmed/32965044 http://dx.doi.org/10.1002/jimd.12317 |
Ejemplares similares
-
Arginine therapy in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes
por: Ikawa, Masamichi, et al.
Publicado: (2020) -
Metabolic manipulators: a well founded strategy to combat mitochondrial dysfunction
por: Koene, Saskia, et al.
Publicado: (2010) -
Biochemical diagnosis of mitochondrial disorders
por: Rodenburg, Richard J. T.
Publicado: (2010) -
COA7 (C1orf163/RESA1) mutations associated with mitochondrial leukoencephalopathy and cytochrome c oxidase deficiency
por: Martinez Lyons, Anabel, et al.
Publicado: (2016) -
Anticonvulsant Medications in Mitochondrial Disease
por: Mithal, Divakar S., et al.
Publicado: (2017)